Polysaccharide peptide from Ganoderma lucidum (beta-1,3/1,6-D-Glucan)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Polysaccharide peptide from Ganoderma lucidum (beta-1,3/1,6-D-Glucan), covering 2021-10-15 to 2021-10-15. Get the full timeline:
Most recent: Clinical Trial Update: Development The Potentiality of β-1,3/1,6-D-Glucan (Polysaccharide Peptide) From Mycelia Extract of Indonesia's Ganoderma Lucidum as Adjuvant Therapy in Patients With Cardiometabolic Syndrome [Phase 2]